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Abstract: Exposure to glucocorticoids leads to numerous changes in various biological systems including the reproductive system. The
aim of the present work was to find out whether dexamethasone (Dx) treatment of adult female rats would influence the histological and
morphometric characteristics of the pituitary gonadotrophic cells (luteinizing - LH cells and follicle stimulating - FSH cells). One group
of female Wistar rats received Dx injections on three consecutive days in doses 1.0, 0.5 and 0.5 mg/kg b.w. respectively, while the control
rats were treated with equivalent volumes of saline. Experimental and control animals were sacrificed 24 h and 72 h after the last injection.
The peroxidase-antiperoxidase (PAP) immunocytochemical procedure was used to study the LH and FSH cells. The stereological and
morphometric analyses showed that multiple Dx treatments of female rats significantly decreased the volume of LH cells and
the volume of their nuclei 24 h and 72 h after the last Dx injection in comparison with control values. At 24 h after Dx treatment,
the volume density of LH cells was significantly increased, but at 72 h differences between the experimental and control groups
were insignificant. The increase in number of LH cells per unit area (mm2) was significant at both timepoints (24 h and 72 h).
Stereologic and morphometric characteristics of FSH cells was changed after Dx treatment in the same manner as that of LH cells, except
for the volume density, where a significant increase was established 24 h and 72 h after the last Dx application. These results clearly
demonstrate that 24 h and 72 h after the last of three Dx injections there were changes in the immunocytochemical and morphometric
features of gonadotrophic cells. (www.cm-uj.krakow.pl/FHC)
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Introduction
Activation of the hypothalamic-pituitary-adrenal (HPA)
axis by a variety of stressors is associated with changes
in gonadotrophin secretion and disruption of ovarian
cyclicity [7]. Glucocorticoids, the end product of the
HPA axis have also been known to interrupt normal
gonadotrophin secretion, acting at the level of the hypo-
thalamus, pituitary gland and ovaries [26]. It is interes-
ting that glucocorticoids affect the two gonadotrophins
differently: plasma concentrations and pituitary content
of follicle stimulating hormone (FSH) increased follow-
ing exposure to stress or glucocorticoid administration
[17, 26], whereas serum luteinizing hormone (LH) le-
vels decreased but the pituitary content of LH was
unchanged. The decline in plasma LH after elevation of
glucocorticoid level blocks ovulation by preventing the
preovulatory surges [15]. However, the increased syn-
thesis and storage of FSH in the pituitary gland and the
increase in plasma concentrations in this condition, may
assist in the restoration of ovulatory cycles and repro-
ductive functions after glucocorticoid levels fall [13]. 
It has been reported that glucocorticoids cause
changes in plasma gonadotrophin levels and their pitui-
tary content, and indirectly contribute to the inhibition
of reproductive functions. In the present study, we in-
vestigated the effects of dexamethasone on immunocy-
tochemical and morphometric characteristics of LH and
FSH cells in adult female rats. We were also interested
whether the intensity of any changes in the gonadotro-
phic cells alter in the period from 24 h to 72 h after
multiple dexamethasone treatment.
Materials and methods
Animals. Three-month-old virgin Wistar female rats were reared in
the Institute for Biological Research in Belgrade, under standard
conditions of controlled temperature (22°C), and a 12 h light/dark
cycle. Food and water were freely available. The animals were
divided into four groups. The experimental groups (Dx 24; n=8 and
Dx 72; n=8) received subcutaneous injections of 1.0, 0.5 and 0.5 mg
Dx (Dexamethasone phosphate - Krka, Novo Mesto, dissolved in
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0.9% saline)/kg b.w. on three consecutive days, respectively, and
were sacrificed at 10 a.m. by decapitation under ether anesthesia, 24
h or 72 h after the last injection. Control groups (C 24; n=8 and C
72; n=8) were injected with 0.9% saline in equal volumes as for the
experimental groups, and were decapitated 24 h and 72 h after the
last injection. Since the examined histological and morphometric
parameters showed no significant differences between groups C 24
and C 72, all data were combined into one control group (C).
Light microscopy and immunocytochemistry. The pituitary
glands were excised, fixed in Bouin’s solution for 48 h and em-
bedded in paraffin wax. Serial 5 µm thick tissue sections were
deparaffinized in xylol and decreasing series of ethanol. Pituitary
hormones were localized immunohistochemically using the perox-
idase-anti-peroxidase complex (PAP) method of Sternberger [23].
Endogenous peroxidase activity was blocked by incubation in meth-
anol containing 0.3% H2O2 for 15 min at room temperature, fol-
lowed by a rinse in 0.1 M phosphate buffered saline (PBS; pH 7.4)
for 5 min. Before application of specific primary antibodies, non-
specific background staining was prevented by incubation for 45
min with nonimmune serum, i.e. normal porcine serum diluted 1:10
v/v in PBS; and then incubated with primary antibody for 45 min at
room temperature. Antisera for βLH and βFSH (gifts from Dr A. F.
Parlow, National Institute of Health, Bethesda, MD, USA) were
diluted with PBS; 1:500 for βLH and 1:300 for βFSH. Subsequent
to a 5 min rinse in PBS, the sections were incubated for 45 min with
secondary antibody (1:500 v/v swine anti-rabbit IgG; DAKO A/S,
Glostrup, Denmark), rinsed for 5 min in PBS, incubated for 45 min
with rabbit antiperoxidase serum (1:100; DAKO A/S, Glostrup,
Denmark), and again rinsed in PBS. The antigen-antibody complex
was visualised by incubating the sections with 0.05% 3,3’-diami-
nobenzidine (DAB; Serva, Heidelberg, Germany) and 0.03% H2O2.
The incubated sections were counterstained with haematoxylin.
Control sections were incubated with normal porcine serum without
primary antisera.
Morphometry. Immunocytochemically stained sections of pitui-
taries cut at three tissue levels of the pars distalis were used for
morphometric examinations of anti-rat LH and anti-rat FSH reactive
cells with visible nuclei. The cell volume of gonadotrophs (Vc), their
volume densities (VV) and the volume of the nucleus (Vn) were
measured in 50 test areas per pituitary gland under a light microscope
at the magnification of × 1000, on 5 µm thick sections, using the M42
multipurpose test system [27]. The volumes of LH- and FSH-positive
cells and their nuclei were expressed in µm3. Volume densities of
gonadotrophic cells were expressed as percentages of total pituitary cells
in mm3. At the same time, the number of immunoreactive cells per unit
area (mm2) was analyzed in each section, by simple point counting.
Digital images were made using a DM RB Photomicroscope
(Leica, Wetzlar, Germany) with a JVC TK 1280E Video Camera
(Leica). For image acquisition Qwin program (Leica) was used.
Statistical analysis. Morphometric data obtained from each rat
were averaged per experimental group and mean and standard
deviations were calculated. One-way analysis of variance, followed
by Duncan’s multiple range test, was used for statistical comparison




The gonadotrophic cells of the control females were
large, polygonal, oval or polyhedral in shape, with
prominent, often eccentrically located nuclei. They
showed strong immunopositivity for LH and FSH and
were positioned throughout the pituitary pars distalis
alone or in groups, often in close contact with blood
capillaries (Figs. 1a, 2a).
Fig. 1. Pars distalis of the adenohypophysis of control and Dx-treated
female rats; (a) immunoreactive βLH cells in a control rat (bar=13
µm); (b) immunoreactive βLH cells 24 h after Dx treatment (bar=13
µm); (c) immunoreactive βLH cells 72 h after Dx treatment (bar=13
µm); insets (bar=8 µm). 
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After Dx treatment, the LH cells were more in-
tensely immunostained than in the controls, smaller
in size but more numerous and with granulated cyto-
plasm (Figs. 1b,c). FSH cells after Dx treatment were
weakly immunocytochemically stained, numerous and
smaller than the FSH cells in control animals (Figs.
2b,c). 
Morphometric analysis
LH cells. Stereological analysis showed that multiple
Dx treatment led to significant changes in LH cells 24
h and 72 h after the last Dx administration. The volume
of immunopositive LH cells was reduced at each time-
point by 31% (p<0.05) and 19% (p<0.05) respectively,
compared with the control values (Fig. 3a). The nuclear
volume of LH-positive cells was decreased by 57%
(p<0.05) at 24 h, and by 52% (p<0.05) at 72 h in
comparison with control females (Fig. 3b). The percent-
age of LH cells per unit volume of total pituitary gland
tissue, i.e. the volume density was increased by 20%
(p<0.05) in experimental group Dx 24, but insignifi-
cantly changed in Dx 72 group, (Fig. 3c). In the pitui-
tar ies of  Dx-treated rats, the number of LH
immunoreactive cells, per unit area (mm2) was in-
creased by 21% (p<0.05) at 24 h and by 8% (p<0.05) at
72 h, as compared with the controls (Table 1).
When the values for the two experimental groups were
compared, the following results were obtained. The mean
volume of LH-positive cells in group Dx 72 was by 17%
larger (p<0.05), than that for group Dx 24 (Fig. 3a). The
mean volume of the nuclei in LH-positive cells in group
Dx 72 was also significantly increased (by 13%; p<0.05),
in comparison with Dx 24 (Fig. 3b). The volume density
and number per unit area of LH-positive cells were re-
duced by 18% (Fig. 3c) and 11% (Table 1), respectively,
and the differences between the groups were again
statistically significant (p<0.05). The LH cells 72 h after
Dx treatment showed weaker immunostaining than LH
cells 24 h after Dx treatment (Figs. 1b,c).
FSH cells. Multiple Dx treatment led to similar changes
in the stereological and morphometric paramethers of
FSH cells 24 h and 72 h after the last dose of Dx, as for
LH cells. Thus, the volume of immunopositive FSH
cells was decreased by 12% (p<0.05) at 24 h and by 9%
(p<0.05) at 72 h (Fig. 3a), and the volume of their nuclei
was also reduced at each timepoint by 26% (p<0.05)
and by 19% (p<0.05), respectively, in comparison with
the controls (Fig. 3b). The volume density of FSH-posi-
tive cells 24 h and 72 h after Dx treatment was increased
by 12% (p<0.05) and by 9% (p<0.05), respectively (Fig.
3c). The number of FSH cells per unit area (mm2) was
increased by 39% (p<0.05) at 24 h and by 41% (p<0.05)
at 72 h in comparison with the control rats (Table 1).
When the values for the Dx 24 and Dx 72 were
compared, the following results were obtained. The
mean volume of FSH-positive cells in group Dx 72 was
insignificantly increased (by 4%), in comparison with
Dx 24 (Fig. 3a). The mean volume of the nuclei in
FSH-positive cells in group Dx 72 was significantly
Fig. 2. Pars distalis of the adenohypophysis of control and Dx-treated
female rats; (a) immunoreactive βFSH cells in a control rat (bar=13
µm); (b) immunoreactive βFSH cells 24 h after Dx treatment (bar=13
µm); (c) immunoreactive βFSH cells 72 h after Dx treatment (bar=13
µm); insets (bar=8 µm).
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increased (by 10%; p<0.05), (Fig. 3b), but the volume
density and number per unit area of FSH-positive cells
were not significantly changed (Fig. 3c, Table 1) in
comparison with Dx 24. The FSH cells 72 h after Dx
treatment were slightly more intensely immunostained
than FSH cells 24 h after Dx treatment (Figs. 2b, c). 
Discussion
Our results have shown that Dx treatment of female rats
caused significant reductions of both cell and nuclear
volume of LH and FSH cells, together with an increase
in their volume density and number per unit area, 24 h
and 72 h after the last Dx injection. 
Dexamethasone is often used in medical practice to
treat a wide variety of pathological states [12], as well
as in studies of stress-induced effects of glucocorticoids.
Its action is mediated through the activation of intracel-
lular glucocorticoid receptors, which are expressed in
almost all cell types [1]. 
It is possible that glucocorticoids have more than one
site of action on LH cells, but the most important is the
control of LH function at the level of the hypothalamus
and pituitary gland [6]. 
Some of the effects of glucocorticoids on LH cells
may be due to inhibition of gonadotrophin-releasing
hormone (GnRH) secretion, the major controller of LH
and FSH cell function [8]. The presence of glucocorti-
coid receptors (GR) in GnRH neurons [2] indicates that
glucocorticoids act at the level of the hypothalamus.
Glucocorticoids directly inhibit the expression of GnRH
genes and GnRH secretion [5] associated with a decline
in portal GnRH concentrations [19]. The effects of glu-
cocorticoids on GnRH neurons are due at least partially
to a decline in LH synthesis [10], with a consequent
decrease in LH cell and nuclear volume, as seen in our
experimental groups Dx 24 and Dx 72. It is also interes-
ting that treatment of female rats with glucocorticoids in
the absence of a GnRH signal, had no influence on α and
β  LH mRNA levels and LH synthesis [13]. It is possible
that GnRH neurons are the key site of glucocorticoid
action on the synthetic function of LH cells. However,
the ability of glucocorticoids to inhibit LH secretion in
vitro [3] suggests that they can directly affect LH cells
through the glucocorticoid receptor, at the pituitary level
[11]. Ringstrom et al. [17] observed that the main in-
fluence of glucocorticoids on LH cells seems to be
blocking the release of LH, as manifested in our results
Table 1. The number (No) of immunoreactive LH and FSH cells per
unit area (mm2) in control and Dx-treated female rats 24 h and 72 h
after the last Dx injection. 
LH cells C Dx 24 Dx 72




FSH cells C Dx 24 Dx 72
No/mm2 168±6 234±6 238±9
(+39%)a (+41%)a
Results are means ±SD (n=8). ap<0.05 (C vs. Dx 24; C vs. Dx 72),
bp<0.05 (Dx 24 vs. Dx 72).
Fig. 3. (a) The cell volume (Vc) of LH- and FSH-immunopositive
cells of control (C) and Dx-treated female rats 24 h (Dx 24) and 72
h (Dx 72) after the last Dx dose. (b) The nuclear volume (Vn) of LH-
and FSH-immunopositive cells of control and Dx- treated female rats
24 h and 72 h after the last Dx dose. (c) Volume density (Vv) of
immunoreactive LH and FSH cells expressed as a percentage of total
adenohypophyseal cells volume in control and Dx-treated rats 24 h
and 72 h after the last Dx dose. All values are means ±SD, n=8.
ap<0.05 (C vs. Dx 24; C vs. Dx 72), bp<0.05 (Dx 24 vs. Dx 72). 
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by intense immunocytochemical staining of LH cells
after Dx treatment. The finding that glucocorticoids
inhibit calcium ionophore-stimulated release of LH in-
dicated that the release mechanism is disrupted [10].
Tohei and Kogo [26] also suggest that exposure to
glucocorticoids generally suppresses serum LH levels,
without affecting pituitary content of LH. It is obvious
that the decrease in LH cell volume found in our study
was accompanied by an increase in the number of LH
cells. Some of the LH cells containing trace amounts of
hormones could not be visualized by immunocyto-
chemical staining in control females, but after Dx treat-
ment they became visible and available for stereological
and morphometric analyses. This could also contribute
to the increase in the number of LH cells observed in
experimental animals. Such compensatory effect con-
tributes to the maintenance of LH content in the pituitary
gland after exposure to glucocorticoids. 
Glucocorticoids may reduce the pituitary response to
GnRH [25] by acting directly or indirectly on gonado-
trophic cells to inhibit their responsiveness to GnRH.
Consistent with a direct action, the glucocorticoid recep-
tor has been identified within gonadotrophs [11]. This
receptor, however, has also been localized in folliculos-
tellate cells within the pituitary [16]. Folliculostellate
cells respond to glucocorticoids by synthesizing an-
nexin-1, an inhibitory paracrine factor, with a receptor
in gonadotrophic cells [22]. It is possible, therefore, that
the inhibitory effects of glucocorticoids on the respon-
siveness to GnRH, as well as on LH release could be
mediated indirectly via annexin-1 from folliculostellate
cells [4, 9]. 
Glucocorticoid receptors are also present in the
ovaries [21]. However, few data have shown the effects
of dexamethasone on ovarian function in vivo. Tohei and
Kogo [26] suggest that dexamethasone inhibits ovarian
function and synthesis of inhibin and estradiol. Dexa-
methasone also reduces the ability of estrogen to stimu-
late LH secretion [10]. Thus, it is possible that under
these circumstances, ovarian feedback effects have no
important influence on LH secretion, but they are very
important in the regulation of FSH secretion. 
Decreases in FSH cell and nuclear volume, as well
as increases in volume density and number per unit area
were found in this study 24 h and 72 h after the last Dx
dose. Decrease in cell volume and weak immunoposi-
tivity of FSH cells after Dx treatment could be a conse-
quence of stimulated FSH release. It is interesting that
glucocorticoids can stimulate FSH release by direct
action on FSH cells [17] and by inhibition of the ovarian
function [20] and inhibin secretion from ovarian granu-
losa cells [26]. Increase in the volume density and num-
ber of FSH-positive cells in the same experimental
conditions are in accordance with the increase in tissue
level of FSH reported by McAndrews et al. [13]. Ring-
strom et al. [17] observed that exposure to glucocorti-
coids in vivo significantly elevated the pituitary content
of FSH, mainly by increasing its synthesis or blocking
intracellular degradation by direct action on the gonado-
trophs and these effects were independent of endogen-
ous GnRH. 
Glucocorticoids can stimulate FSH synthesis by in-
fluencing FSH genes [18]. Thus, treatment with gluco-
corticoids increases pituitary FSH mRNA and pituitary
content of FSH [13], suggesting that glucocorticoids
affect FSH at the pituitary level directly rather than via
the hypothalamus. 
It is obvious that multiple dexamethasone treatment
changed the dynamics of pituitary gonadotroph popula-
tions and caused an increase in volume density and
number per unit area of FSH cells. It is well known that
dexamethasone inhibits mitotic activity of pituitary cells
[14], therefore the increase in FSH cell number could be
a result of differentiation from undifferentiated pituitary
cells or stem cells which are the major source of a newly
formed pituitary cells under various physiological con-
ditions [24]. Also, some of the FSH cells, as well as LH
cells, became visible and available for stereological and
morphometric analyses after Dx treatment, and that
could contribute to the increase in number of these cells.
Increases in volume density and number of FSH cells
after Dx administration allow storage of more FSH in
the pituitary gland.
Thus, our results showed that between 24 h and 72 h
after the last dose of Dx there was an increase in LH cell
and nuclear volume, together with a decrease in their
volume density and number per unit area, i.e. the values
for Dx 72 group approached those found in the control
group. The intensity of immunostaining of LH cells in
Dx 72 group was lower than in Dx 24 group. Changes
in these parmeters indicate a gradual normalization of
LH cell function with time after the treatment. Stereo-
logical and morphometric parameters, as well as intens-
ity of immunostaining of FSH cells in Dx 72 group were
only slightly changed in comparison with Dx 24 group.
This indicates that normalization of FSH cell function after
Dx treatment needs more time than normalization of LH
cell function in the same experimental conditions. 
Besides confirming that elevated levels of glucocor-
ticoids cause significant changes in the stereologic and
morphometric paramethers of LH and FSH cells, we
have also shown that the changes after Dx treatment are
reversible, as the effects decrease with time after treat-
ment allowing for normalization of the gonadotroph
function. These results are important in view of wide-
spread dexamethasone use in clinical practice.
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